Overview

  • Product nameAnti-ENTPD8 antibody
    See all ENTPD8 primary antibodies
  • Description
    Rabbit polyclonal to ENTPD8
  • Tested applicationsSuitable for: WB, Blockingmore details
  • Species reactivity
    Reacts with: Hamster, Human
  • Immunogen

    KLH conjugated synthetic peptide corresponding to a region within C terminal amino acids 404-434 of Human ENTPD8.

  • Positive control
    • K562 and CHO cell lysates

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab103735 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 54 kDa.
Blocking Use at an assay dependent concentration. PubMed: 22792409

Target

  • RelevanceENTPD8 is a canalicular ectonucleoside NTPDase responsible for the main hepatic NTPDase activity. Ectonucleoside NTPDases catalyze the hydrolysis of gamma- and beta-phosphate residues of nucleotides, playing a central role in concentration of extracellular nucleotides. Has activity toward ATP, ADP, UTP and UDP, but not toward AMP. There are two different isoforms.
  • Cellular localizationCell membrane; Multi-pass membrane protein
  • Database links
  • Alternative names
    • E NTPDase 8 antibody
    • EC 3.6.1.5 antibody
    • ecto-ATP-diphosphohydrolase antibody
    • Ectonucleoside triphosphate diphosphohydrolase 8 antibody
    • GLSR2492 antibody
    • liver ecto ATP diphosphohydrolase antibody
    • NTPDase 8 antibody
    • nucleoside triphosphate diphosphohydrolase-8 antibody
    • UNQ2492 antibody
    see all

Anti-ENTPD8 antibody images

  • Anti-ENTPD8 antibody (ab103735) at 1/100 dilution + K562 cell lysate at 35 µg

    Predicted band size : 54 kDa
  • Anti-ENTPD8 antibody (ab103735) at 1/100 dilution + CHO cell lysate at 35 µg

    Predicted band size : 54 kDa

References for Anti-ENTPD8 antibody (ab103735)

This product has been referenced in:
  • Visovatti SH  et al. Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension. PLoS One 7:e40829 (2012). Blocking ; Human . Read more (PubMed: 22792409) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab103735.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"